Cite
HARVARD Citation
Otowa, Y. et al. (2016). Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer. Diseases of the esophagus. 29 (2), pp. 146-151. [Online].